See every side of every news story

Published 3 days ago • loading... • Updated 3 days ago

Abstract: Delta-Fly Pharma, Inc: Progress of the development status of the combination study of DFP-10917 with venetoclax

Summary by Fintech News

TOKUSHIMA, Japan–(BUSINESS WIRE)–As a follow-up to the previous information on December 9, 2024, we are pleased to share our latest development status. Regarding the Phase I/II clinical trial of DFP-10917 in combination with Venetoclax (VEN) in patients with acute myeloid leukemia (AML) in second-line treatment (NCT06382168), the Data Management Committee (DMC) has cleared the tolerability of all six patients in the Phase I (dose-finding) porti…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

1 Articles

All

Left

Center

Right

Abstract: Delta-Fly Pharma, Inc: Progress of the development status of the combination study of DFP-10917 with venetoclax

TOKUSHIMA, Japan–(BUSINESS WIRE)–As a follow-up to the previous information on December 9, 2024, we are pleased to share our latest development status. Regarding the Phase I/II clinical trial of DFP-10917 in combination with Venetoclax (VEN) in patients with acute myeloid leukemia (AML) in second-line treatment (NCT06382168), the Data Management Committee (DMC) has cleared the tolerability of all six patients in the Phase I (dose-finding) porti…

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated3 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Fintech News broke the news in 3 days ago on Saturday, March 1, 2025.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content. Stay informed with comprehensive global news coverage all in one place. Subscribe now to compare different perspectives, identify biases, and stay ahead of algorithms